[HTML][HTML] Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

J Soppert, M Lehrke, N Marx, J Jankowski… - Advanced drug delivery …, 2020 - Elsevier
With cardiovascular disease being the leading cause of morbidity and mortality worldwide,
effective and cost-efficient therapies to reduce cardiovascular risk are highly needed. Lipids …

The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease

S Hartmann, AJ Ridley, S Lutz - Frontiers in pharmacology, 2015 - frontiersin.org
Rho-associated kinases ROCK1 and ROCK2 are serine/threonine kinases that are
downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in …

Water-based polyurethane 3D printed scaffolds with controlled release function for customized cartilage tissue engineering

KC Hung, CS Tseng, LG Dai, S Hsu - Biomaterials, 2016 - Elsevier
Conventional 3D printing may not readily incorporate bioactive ingredients for controlled
release because the process often involves the use of heat, organic solvent, or crosslinkers …

Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction

EM Small, JE Thatcher, LB Sutherland… - Circulation …, 2010 - Am Heart Assoc
Rationale: Myocardial infarction (MI) results in loss of cardiac myocytes in the ischemic zone
of the heart, followed by fibrosis and scar formation, which diminish cardiac contractility and …

Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection

DJ Hausenloy, DM Yellon - Heart failure reviews, 2007 - Springer
Following an acute myocardial infarction (AMI), early coronary artery reperfusion remains
the most effective means of limiting the eventual infarct size. The resultant left ventricular …

Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease

Z Liu, RA Khalil - Biochemical pharmacology, 2018 - Elsevier
Vascular smooth muscle (VSM) plays an important role in the regulation of vascular function.
Identifying the mechanisms of VSM contraction has been a major research goal in order to …

Rho kinases in cardiovascular physiology and pathophysiology

G Loirand, P Guérin, P Pacaud - Circulation research, 2006 - Am Heart Assoc
Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein
RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have …

Rho kinase (ROCK) inhibitors

JK Liao, M Seto, K Noma - Journal of cardiovascular …, 2007 - journals.lww.com
The Rho kinase (ROCK) isoforms, ROCK1 and ROCK2, were initially discovered as
downstream targets of the small GTP-binding protein Rho. Because ROCKs mediate various …

Rho-kinase is an important therapeutic target in cardiovascular medicine

H Shimokawa, A Takeshita - Arteriosclerosis, thrombosis, and …, 2005 - Am Heart Assoc
Rho-kinase has been identified as one of the effectors of the small GTP-binding protein Rho.
Accumulating evidence has demonstrated that Rho/Rho-kinase pathway plays an important …

Applications for ROCK kinase inhibition

MF Olson - Current opinion in cell biology, 2008 - Elsevier
ROCK kinases, which play central roles in the organization of the actin cytoskeleton, are
tantalizing targets for the treatment of human diseases. Deletion of ROCK I in mice revealed …